CVE-2022-34317 — MEDIUM (5.4)

Vulnerability Description

IBM CICS TX 11.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 229459.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Ibm	Cics Tx	11.1

Related Weaknesses (CWE)

CWE-79

References

https://exchange.xforce.ibmcloud.com/vulnerabilities/229459VDB EntryVendor Advisory
https://www.ibm.com/support/pages/node/6833180PatchVendor Advisory
https://www.ibm.com/support/pages/node/6833182PatchVendor Advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/229459VDB EntryVendor Advisory
https://www.ibm.com/support/pages/node/6833180PatchVendor Advisory
https://www.ibm.com/support/pages/node/6833182PatchVendor Advisory

FAQ

What is CVE-2022-34317?

CVE-2022-34317 is a vulnerability with a CVSS score of 5.4 (MEDIUM). IBM CICS TX 11.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading t...

How severe is CVE-2022-34317?

CVE-2022-34317 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-34317?

Check the references section above for vendor advisories and patch information. Affected products include: Ibm Cics Tx.